FDA Grant to Study Septic Shock in Humans
Kupper Parker CommunicationsFDA has awarded a six-month $100,000 SBIR grant to MetaPhore Pharmaceuticals to study the dramatic and perplexing blood pressure drop that occurs during septic shock and leads to death in up to 50 percent of cases.